CaTe Inc.
As of February 2024
City | Year of Establishment | Founder |
---|---|---|
Bunkyo-ku, Tokyo | 2020 | Kazuhiro Terashima |
Partner VC | Latest round of Fundraising | Valuation |
---|---|---|
Jafco Group Co., Ltd. | Series A | JPY 1,115 million |
- Contact Information : 03-6273-8578
- cate1@cate.co.jp
- Website : CaTe Inc.
Program name
Deep-Tech Startups Support Program
Research theme
Development of exercise workload optimization function and cardiac rehabilitation program medical device
Business Plan
Although cardiac rehabilitation has proven therapeutic benefits for patients with cardiac disease, participation in outpatient cardiac rehabilitation in Japan is low, at about 4-8%, resulting in many cardiac patients being repeatedly re-hospitalized, and society as a whole is burdened with medical costs. CaTe aims to create a healthier future by providing appropriate exercise therapy and behavior modification for a variety of patients, including those with cardiac disease, thereby creating an environment in which many patients can receive better medical care at home.
Research Outline
This research and development will develop a cardiac rehabilitation program medical device that will realize exercise therapy in a standing position that is both effective and safe by developing an exercise load volume optimization function.
- Development of the function to optimize the amount of exercise load
- Develop a cardiac rehabilitation program medical device equipped with (1)
- Conduct exploratory investigator-initiated trials
- Preparation of a validative clinical trial including protocol development.
Phase | Business Area/Field | Research Period | Research Grant Amount |
---|---|---|---|
STS | Healthcare | 2023~2024 FY | JPY 191 million |
Last Updated : June 6, 2024